DOCSLIB.ORG

New State-Run Vaccination Sites Open

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
New State-Run Vaccination Sites Open IN THE NEWS New State-run vaccination sites open Two new State-run sites opened last weekend – in South County, at the Schnei- der Electric facility, 132 Fairgrounds Road, West Kingston, and in Woonsocket at the old Sears department store at 1500 Diamond Hill Road. Both of these new sites vaccinated 400 Current Sites residents with the first dose of the Pfizer vaccine. Officials say they are prepared to 1500 Diamond Hill Road, Woonsocket administer many more doses per day when 132 Fairgrounds Road, West Kingston the supply comes in. The sites were run with 1400 West Main Road, Middletown help from the Rhode Island Medical Reserve 100 Sockanosset Cross Road, Cranston Corps and hundreds of volunteers. Dunkin Donuts Center, Both sites will operate from 2 to 6 p.m. 1 La Salle Square, Providence Appointments will be available through vaccinateRI.org. In addition to these sites, the Rhode Island Dept. of Health (RIDOH) is work- ing to open locations in Westerly, East Providence, and Johnston. As vaccine supplies increase, more appointments will become available at these sites and others. The state currently has the capacity to administer about 100,000 doses, and that number is expected to increase to more than 165,000 doses per week. Warren residents Bernard Kwan and Sheila Dai were Eligibility Timeline among the first to be vaccinated at the Middletown site All Rhode Islanders will be eligible to make an appointment to be vaccinated and expressed their gratitude to VA nurses and FEMA by April 19. The State is currently vaccinating people who are age 64 to 60 and for the seamless operation they experienced. people who are age 64 to 16 with underlying health conditions. Eligibility to [PHOTOS COURTESY OF SHEILA DAI] the remaining groups is expected by the following dates: • People age 59 to 50 by April 5 Vaccine eligibility expands for Veterans, spouse, caregivers • People age 49 to 40 by April 12 All Veterans, their spouses and caregivers can get COVID-19 vaccinations from VA • People age 39 to 16 by April 19 under the SAVE LIVES Act signed into law March 24. In some of Rhode Island’s hardest-hit Covered individuals can receive a vaccine from VA due to the ongoing COVID-19 zip codes in Providence, residents 18 and public health emergency. Under the bill, covered individuals are: older already are able to sign up for a vac- • Veterans who are not eligible to enroll in the VA health care system cine through VaccinatePVD.com or by • specified Veterans who are eligible for hospital care, medical services, calling the Providence mayor’s office at and nursing home care abroad 401-421-2489. In Pawtucket and Central • family caregivers approved as providers of personal care services for Veterans Falls, all residents 18 or older are eligible under the VA’s Program of Comprehensive Assistance for Family Caregivers for a shot. v • caregivers of Veterans participating in the VA’s Program of General Caregiver Support Services • caregivers of Veterans participating in the VA’s Medical Foster Home Program, Bowel and Bladder Program, Home Based Primary Care Program, or Veteran Directed Care Program • Civilian Health and Medical Programs of the Department of Veterans Affairs recipients • Veteran spouses VA must prioritize the vaccination of (1) Veterans enrolled in the VA health care system, (2) Veterans who fail to enroll but receive hospital care and medical ser- vices for specified disabilities in their first 12 months of separation from service, and (3) caregivers accompanying such prioritized Veterans. Additionally, vaccines A State-run COVID-19 vaccination clinic furnished abroad are authorized to be furnished in a geographic location other opened last month at the former Benny’s site than a state regardless of whether vaccines are needed for the treatment of Veter- in Middletown; the first site run by the Federal ans with a service-connected disability. This includes those participating in a VA Emergency Management Agency (FEMA). rehabilitation program. v RIMJ ARCHIVES | APRIL ISSUE WEBPAGE | RIMS APRIL 2021 RHODE ISLAND MEDICAL JOURNAL 72 IN THE NEWS CDC real-world study confirms protective benefits of mRNA COVID-19 vaccines Study involved health care personnel, first responders, and essential workers in six states A new CDC study provides strong evidence that mRNA study demonstrates that these two mRNA vaccines can reduce COVID-19 vaccines are highly effective in preventing SARS- the risk of all SARS-CoV-2 infections, not just symptomatic CoV-2 infections in real-world conditions among health care infections. personnel, first responders, and other essential workers. These This is important because preventing both asymptomatic groups are more likely than the general population to be ex- and pre-symptomatic infections among health care workers and posed to the virus because of their occupations. other essential workers through vaccination can help prevent The study looked at the effectiveness of Pfizer-BioNTech and the spread of SARS-CoV-2 to those they care for or serve. Find- Moderna mRNA vaccines in preventing SARS-CoV-2 infections ings from this study complement earlier reports that these two among 3,950 study participants in six states over a 13-week pe- mRNA COVID-19 vaccines can reduce both asymptomatic and riod from December 14, 2020 to March 13, 2021. symptomatic SARS-CoV-2 infections. Results showed that following the second dose of vaccine (the This study also provided positive news about partial (one- recommended number of doses), risk of infection was reduced dose) vaccination. The one-dose VE estimate of this study (80 by 90 percent two or more weeks after vaccination. Following a percent) is consistent with other recent VE studies following single dose of either vaccine, the participants’ risk of infection the first dose of Pfizer-BioNTech vaccine among health care with SARS-CoV-2 was reduced by 80 percent two or more weeks providers. Studies conducted in the United Kingdom and Isra- after vaccination. el showed that one dose was about 70 percent and 60 percent It takes about two weeks following each dose of vaccine for effective, respectively, against SARS-CoV-2 infection. The cur- the body to produce antibodies that protect against infection. rent results provide reassurance that people start to develop As a result, people are considered “partially vaccinated” two protection from the vaccine two weeks after their first dose. weeks after their first dose of mRNA vaccine and “fully vacci- The greatest protection was seen among those who had received nated” two weeks after their second dose. These new vaccine both recommended doses of the vaccine. effectiveness findings are consistent with those from Phase 3 This CDC study was conducted through the HEROES- clinical trials conducted with the vaccines before they received RECOVER network, a network of prospective cohorts that share Emergency Use Authorizations from the Food and Drug Admin- a common protocol and methods. This network is part of a vac- istration. Those clinical trials evaluated vaccine efficacy against cine effectiveness surveillance system made possible by federal COVID-19 disease, while this study evaluated vaccine effective- pandemic flu preparedness funding. ness against infection, including infections that did not result This study is the first of many planned COVID-19 vaccine in symptoms. effectiveness studies CDC is conducting to evaluate the ben- “This study shows that our national vaccination efforts are efits of COVID-19 vaccines in various populations and across working. The authorized mRNA COVID-19 vaccines provid- different outcomes, such as preventing infections, doctor’s vis- ed early, substantial real-world protection against infection for its, hospitalizations, or deaths. Results from these studies assist our nation’s health care personnel, first responders, and other the medical and public health experts on the Advisory Com- frontline essential workers,” said CDC Director ROCHELLE P. mittee on Immunization Practices and CDC to make important WALENSKY, MD, MPH. “These findings should offer hope to vaccine policy decisions aimed at saving lives. v the millions of Americans receiving COVID-19 vaccines each day and to those who will have the opportunity to roll up their sleeves and get vac- RIDOH updates monoclonal antibody treatment regimens cinated in the weeks ahead. The authorized vac- The Rhode Island Department of Health (RIDOH) is committed to ensuring cines are the key tool that will help bring an end timely updates related to the COVID-19 pandemic, including for treatment. to this devastating pandemic.” Based on new guidance issued by the United States (US) Department of One of this study’s strengths is its design: par- Health and Human Services (HHS), and the sustained increase in COVID-19 ticipants self-collected nasal swabs each week variants now circulating in the US that are resistant to bamlanivimab for RT-PCR laboratory testing, regardless of alone, RIDOH no longer recommends the administration of bamlanivimab whether they had developed symptoms of illness. alone to treat people with COVID-19. HHS stopped the distribution of bam- Researchers were able to look for evidence of lanivimab alone starting March 24, 2021. SARS-CoV-2 infection irrespective of symptoms. The US Food and Drug Administration recently updated the authorized A small number (10.7 percent) of infections in this Fact Sheet for Healthcare Providers for the bamlanivimab emergency use study were asymptomatic (i.e., did not result in authorization (EUA). This update advises healthcare providers to use al- symptoms). However, the majority of infections ternative authorized monoclonal antibody therapies that are expected to (58 percent) occurred among people whose infec- protect against circulating viral variants including bamlanivimab and etese- tions were identified by testing before they devel- vimab administered together and casirivimab and imdevimab (Regeneron). oped symptoms or knew they were infected. The RIDOH has updated its healthcare provider page to reflect this change.
Load more

Recommended publications
  • June 11, 2021 the Honorable Xavier Becerra Secretary Department of Health and Human Services 200 Independence Ave S.W. Washingto
    June 11, 2021 The Honorable Xavier Becerra Secretary Department of Health and Human Services 200 Independence Ave S.W. Washington, D.C. 20201 The Honorable Francis Collins, M.D., Ph.D. Director National Institutes of Health 9000 Rockville Pike Rockville, MD 20892 Dear Secretary Becerra and Director Collins, Pursuant to 5 U.S.C. § 2954 we, as members of the United States Senate Committee on Homeland Security and Governmental Affairs, write to request documents regarding the National Institutes of Health’s (NIH) handling of the COVID-19 pandemic. The recent release of approximately 4,000 pages of NIH email communications and other documents from early 2020 has raised serious questions about NIH’s handling of COVID-19. Between June 1and June 4, 2021, the news media and public interest groups released approximately 4,000 pages of NIH emails and other documents these organizations received pursuant to Freedom of Information Act requests.1 These documents, though heavily redacted, have shed new light on NIH’s awareness of the virus’ origins in the early stages of the COVID- 19 pandemic. In a January 9, 2020 email, Dr. David Morens, Senior Scientific Advisor to Dr. Fauci, emailed Dr. Peter Daszak, President of EcoHealth Alliance, asking for “any inside info on this new coronavirus that isn’t yet in the public domain[.]”2 In a January 27, 2020 reply, Dr. Daszak emailed Dr. Morens, with the subject line: “Wuhan novel coronavirus – NIAID’s role in bat-origin Covs” and stated: 1 See Damian Paletta and Yasmeen Abutaleb, Anthony Fauci’s pandemic emails:
    [Show full text]
  • Melissaossmanpro.Pdf
    August 19, 2021 Chairman Lipps, Vice Chair Holmes, Ranking Member Russo, and Members of the House Health Committee, thank you for the opportunity to provide proponent testimony on House Bill 248. My family and I are asking that Ohio HB248 be passed in order to protect the individual freedoms we currently have as American citizens. I work in a corporate setting and my husband owns a small business. We have two young daughters who are relying on us to provide for them and protect their rights. I support this bill in hopes that they can grow up with the same liberties we have had. Segregation and discrimination over individual health choices should be taken seriously and passing this bill is key to avoiding those types of issues in the future. I am not a scientist, but I am a mom, a wife, and a daughter who takes the health of my family very seriously. I have done extensive amounts of research on the SARS-COV2 virus and subsequent vaccines. There are also many health experts that provide me with helpful information. I am sure you are receiving many testimonies about the large numbers of vaccine injuries and even deaths that have occurred during this vaccine campaign. Personally, I know two women who have had severe menstrual issues (requiring surgery) that they can connect back to occurring right after the vaccine. My friends’ cousin passed away at only 23 years old from an enlarged heart after receiving the vaccine. The stories go on and on. The point is that no legislation should force my family and I to inject ourselves with substances that have side effects such as this.
    [Show full text]
  • The Highly Pathogenic Avian Influenza A(H5N1) Virus: a Twenty-Year Journey of Narratives and (In)Secure Landscapes
    The Highly Pathogenic Avian Influenza A(H5N1) Virus: a twenty-year journey of narratives and (in)secure landscapes Philip Rolly Egert Dissertation submitted to the faculty of the Virginia Polytechnic Institute and State University in partial fulfillment of the requirements for the degree of Doctor of Philosophy In Science, Technology, and Society Barbara L. Allen (Chair) Daniel Breslau Bernice L. Hausman David C. Tomblin March 18, 2016 Falls Church, Virginia Keywords: H5N1, HPAI, highly pathogenic avian influenza virus, pandemic, social justice, bioterrorism, bioethics, biopower, tacit knowledge, dual-use dilemma, dual-use research of concern, emerging infectious disease Copyright Philip R. Egert The Highly Pathogenic Avian Influenza A(H5N1) Virus: a twenty-year journey of narratives and (in)secure landscapes Philip Rolly Egert ABSTRACT This dissertation is comprised of two manuscripts that explore various contestations and representations of knowledge about the highly pathogenic avian influenza H5N1virus. In the first manuscript, I explore three narratives that have been produced to describe the 20-year journey of the virus. The journey begins in 1996 when the virus was a singular localized animal virus but then over the next 20 years multiplied its ontological status through a (de)stabilized global network of science and politics that promoted both fears of contagion and politics of otherness. Written by and for powerful actors and institutions in the global North, the narratives focused on technical solutions and outbreak fears. In doing so, the narratives produced policies and practices of biopower that obscured alternative considerations for equity, social justice, and wellbeing for the marginalized groups most directly affected by the H5N1 virus.
    [Show full text]
  • Medical JOUR
    RHODE ISLAND M EDiCAL J ournal ZOOM – It’s a Match! Virtual National Match Day is largest on record See page 75 R SPECIAL SECTION, PART II BIOMEDICAL/TRANSLATIONAL RESEARCH in RI GUEST EDITORS: JAMES PADBURY, MD; BONGSUP CHO, PhD ApRiL 2021 VOLUME 104 • NUMBER 3 iSSN 2327-2228 REINVENTING WHAT YOU EXPECT FROM A MEDICAL PROFESSIONAL LIABILITY PROVIDER. With Coverys, you can reduce the distractions that come between diagnosis and outcomes. By leveraging claims data and analytics plus innovative educational resources, we’re helping doctors and administrators reduce distractions and focus on improving clinical, operational, and financial outcomes.Visit coverys.com Insurance products issued by ProSelect® Insurance Company (NE, NAIC 10638) and Preferred Professional Insurance Company® (NE, NAIC 36234). RHODE ISLAND M EDICAL J OURNAL 15 Translational Research: The Time is Now JAMES F. PADBURY, MD BONGSUP P. CHO, PhD GUEST EDITORS James F. Padbury, MD Bongsup Cho, PhD 17 The Time is NOW: Filling the Gaps in Treatment of Opioid-Exposed Infants: A Prospective, Pragmatic, Randomized Control Drug Trial ADAM J. CZYNSKI, DO; ABBOT R. LAPTOOK, MD 22 COBRE on Opioid and Overdose: A Collaborative Research-Based Center Addressing the Crises in Rhode Island and Beyond TRACI C. GREEN, PhD, MSc; ELIANA KAPLOWITZ, BA; KIRSTEN LANGDON, PhD; JACLYN M.W. HUGHTO, PhD, MPH; WILLIAM C. GOEDEL, PhD; ADAM J. CZYNSKI, DO; GAYLE FRASER, BS; JOSIAH RICH, MD, MPH 27 Brown University COBRE Center for Addiction and Disease Risk Exacerbation PETER M. MONTI, PhD; JENNIFER W. TIDEY, PhD; JASJIT S. AHLUWALIA, MD 32 The Center of Biomedical Research Excellence (COBRE) for Perinatal Biology – Accomplishments, Impact, and Long-term Results SUNIL K.
    [Show full text]
  • Peter Daszak IPBES Scoping for the Nexus Assessment: Health
    IPBES Scoping for the Nexus Assessment: Health & Linkages Peter Daszak [email protected] The focus for this session Three thematic areas: 1. Biodiversity & health 2. Global environmental change & health 3. Food, water & health Your suggestions on: • Scope of the assessment • Questions to address Post-2020 Biodiversity Framework and Global Goals . Aichi Biodiversity Targets, particularly: • Target 14. Biodiversity and Ecosystem Services . Sustainable Development Goals, e.g.: • 3. Health; • 6. Clean Water and Sanitation; • 13. Climate Action; • 14. Aquatic Ecosystems; • 15. Terrestrial Ecosystems; • 17. Partnerships . Global Health Security Agenda (Prevent, Detect, Respond) . Sendai Framework for Disaster Risk Reduction 2015-2030 • Bangkok Principles for implementation of health aspects One Health approach • Health of people, wildlife, livestock, environment • Impact of human-mediated global environmental change on health across all sectors Biodiversity’s Health Services Pharmaceuticals • Penicillin (fungus); Digitalis (foxglove plant); Quinine and quinidine (Peruvian Cinchona tree); Morphine and codeine (poppies); Taxol (Pacific Yew tree) Welfare • Link between good mental health and open spaces, biodiversity, forests/parks • Outdoor activity linked to overall fitness and lack of disease • Dietary diversity and nutritional health Protection against disease • Lower risk emerging diseases from undisturbed intact forest Honey Bee Declines in U.S.A. Biodiversity loss & health Intact Forest Residential Urban Culex mosquitoes prefer
    [Show full text]
  • ISSUE #9 from the Red Patriot Show Some Articles May Require Subscriptions
    J E u l y H 1 T 4 The News t Red R eport h The People • The Right Way , ' 2 1 ISSUE #9 from The Red Patriot Show Some articles may require subscriptions CHINESE-MADE COVID-19 VACCINE RECIPIENTS WON’T COUNT AS VACCINATED: SINGAPORE The Epoch Times Singapore’s health agency said that individuals who have received the Chinese-made COVID-19 vaccine won’t count as being vaccinated. BIDEN ADMIN TO GO “The national vaccination numbers reflect only those vaccinated under the national vaccination program,” the country’s Ministry of ‘DOOR-TO-DOOR’ TO Health said on Tuesday. “Currently, this only includes those vaccinated VACCINATE PEOPLE with the Moderna COVID-19 and Pfizer-BioNTech/Comirnaty vaccines.” America's C itizen Press COVID-19 is the disease caused by the CCP (Chinese Communist Party) virus, otherwise known as the coronavirus. President Joe Biden’s administration plans to go door-to-door to vaccinate people against COVID-19. The city-state’s health officials said there is inadequate efficacy data for “Now we need to go to community-by-community, neighborhood- the Sinovac COVID-19 vaccine, namely against the Delta strain. The by-neighborhood, and oft-times door-to-door, literally knocking variant has become the most prevalent COVID-19 strain in the country. on doors,” said Biden. Watch Biden threaten to send government officials to your door to make you take an OPTIONAL vaccine. WATCH BIDEN While answering a question, Biden appeared to lose his train STRUGGLE TO of thought and completely SPEAK YET forget the name Osama Bin Laden for about five to six AGAIN seconds.
    [Show full text]
  • Lessons from COVID-19 to Help Prevent Future Pandemics
    China CDC Weekly Commentary Lessons from COVID-19 to Help Prevent Future Pandemics Peter Daszak# In just over 12 months since it was first discovered, that allow diseases like COVID-19 to spread globally coronavirus disease 2019 (COVID-19) has caused over within days or weeks (4). Understanding these 100 million confirmed cases and more than 2.2 million patterns, provides the elements of a prevention deaths. Its impact on our global economy has been strategy. staggering and likely to be in the tens of trillions of The first step in any battle is to know your enemy, dollars by the time vaccines are fully deployed (1). and in this case identify the size of the threat and COVID-19 has caused significant hardship, mortality, where it’s coming from. Given that viruses are the and morbidity across the world, from the lockdowns predominant group of pathogens and that most viral experienced by the citizens of Wuhan in early 2020, zoonoses are acquired from mammalian hosts, we through to the waves of case spikes in European, North repeatedly sampled two species of mammals (a fruit bat American, and other countries. Pandemics of this scale and primate) and conducted the same viral discovery are rare, and many have called COVID-19 a once-in-a- protocol on each sample. Using data on the rate of century pandemic, but our research suggests that they discovery of new strains compared to repeat findings, are increasing in frequency, driven by a rise in the we were able to estimate the unknown diversity of animal-to-human pathogen spillover events that viruses in all mammal species — around 1.6 million usually cause them (2).
    [Show full text]
  • Lesson Learned from Emerging Infectious Diseases: Are We Ready for the Next Pandemic?
    Lesson Learned from Emerging Infectious Diseases: Are We Ready for the Next Pandemic? Ching Man Chan, Jenny (2nd year Mphil) Supervisor: Dr. Martin Chan Joint Graduate Seminar Department of Microbiology, Faculty of Medicine, CUHK 13th December, 2018 1 What are Emerging Infectious Diseases? Why does it matters? Emerging Infectious Diseases (EIDs) Definition Increasing frequency to describe the appearance of 1. An unrecognised infection 2. A previously recognised infection → to a new ecological niche/geographical zone → significant change in pathogenicity Facts o Infectious diseases are continuously emerging o Majority of human emerging infectious diseases are zoonoses o Those that are not zoonoses have zoonotic origins o Globalisation and human invasiveness → emergence opportunities (Howard and Fletcher, Emeging Microbes and Infections, 2012; van Doorn, Medicine (Abingdon), 2014) Severity of Emerging Infectious Diseases (Bean et al. Nature Reviews Immunology, 2013) List of Blueprint Priority Diseases 2018 o Crimean-Congo haemorrhagic fever (CCHF) o Ebola virus disease and Marburg virus disease o Lassa fever o Middle East respiratory syndrome coronavirus (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS) o Nipah and henipaviral diseases o Rift Valley fever (RVF) o Zika o Disease X Why most of them are viral diseases? Where do they come from and how they evolve to infect human? Mutation Rate V.S. Genome Size (Gago et al. Science, 2009) Many of the viruses are UNKNOWN (Dr Peter Daszak’s talk on “The beginning of an end to the Pandemic Era”, Uppsala Health Summit, 2017) Emergence of Zoonoses (Wolfe, Dunavan and Diamond. Nature, 2007) Multiple Species Barrier to become Zoonotic (Bean et al.
    [Show full text]
  • The Hunt for Coronavirus Carriers
    Feature ILLUSTRATION BY DAVID PARKINS DAVID BY ILLUSTRATION t was the news Sophie Gryseels had been dreading for months. Almost a year into the pandemic, a seemingly healthy wild mink tested positive for SARS-CoV-2 in Utah. No free-roaming animal was known to have caught the virus before, although research- ers had been watching for this closely. “It’s THE HUNT FOR happened,” wrote Gryseels, an evolution- Iary biologist at the University of Antwerp, Belgium, in an e-mail to her colleagues. Ever since the coronavirus started spreading around the world, scientists have worried that it could leap from people into wild animals. If CORONAVIRUS so, it might lurk in various species, possibly mutate and then resurge in humans even after the pandemic has subsided. That would bring the tale of SARS-CoV-2 full circle, because wild animals probably brought it to humans in the first place. Strong evidence suggests that the virus originated in horseshoe CARRIERS bats (Rhinolophus spp.), possibly hitching a ride on other animals before infecting people1. In the To prevent future outbreaks, scientists current stage of the pandemic, with hundreds of thousands of confirmed COVID-19 infections are studying how the coronavirus leaps every day, people are still driving transmission from humans to animals — and back again. of SARS-CoV-2. But years from now, when com- munity spread has been suppressed, a reservoir By Smriti Mallapaty of SARS-CoV-2 in free-roaming animals could become a recalcitrant source of new flare-ups. Wild animals are not the only ones to have drawn scrutiny.
    [Show full text]
  • Middle East Respiratory Syndrome Coronavirus in Bats, Saudi Arabia
    The Study Middle East In October 2012 and April 2013, three agencies col- lected samples from bats in regions where MERS cases had Respiratory been identified (Figure 1). The agencies are the Ministry of Health of Saudi Arabia, the Center for Infection and Im- Syndrome munity of Columbia University, and EcoHealth Alliance. Coronavirus in During the October investigation, the team inter- viewed the family of an index case-patient in Bisha and Bats, Saudi Arabia collected samples from bats <12 km from his home, in an abandoned date palm orchard, and <1 km from his place Ziad A. Memish, Nischay Mishra, of employment, a hardware store that fronted a garden and Kevin J. Olival, Shamsudeen F. Fagbo, date palm orchard. Although neither family members nor Vishal Kapoor, Jonathan H. Epstein, employees recalled seeing bats, the team observed roosting Rafat AlHakeem, Mushabab Al Asmari, bats and guano in abandoned wells and ruins within 12 km Ariful Islam, Amit Kapoor, Thomas Briese, of his home and insectivorous bats at dusk in the garden Peter Daszak, Abdullah A. Al Rabeeah, behind his store. Over 3 weeks, 96 bats representing 7 spe- and W. Ian Lipkin cies (Rhinopoma hardwickii, Rhinopoma microphyllum, Taphozous perforatus, Pipistrellus kuhlii, Eptesicus bot- The source of human infection with Middle East respi- tae, Eidolon helvum, and Rosettus aegyptiacus) were cap- ratory syndrome coronavirus remains unknown. Molecular investigation indicated that bats in Saudi Arabia are infected tured in mist nets and harp traps, then released after visual with several alphacoronaviruses and betacoronaviruses. speciation and collection of morphometric measurements; Virus from 1 bat showed 100% nucleotide identity to virus wing punch biopsy samples; blood; throat swab samples; from the human index case-patient.
    [Show full text]
  • Prediction and Prevention of the Next Pandemic Zoonosis
    Series Zoonoses 3 Prediction and prevention of the next pandemic zoonosis Stephen S Morse, Jonna A K Mazet, Mark Woolhouse, Colin R Parrish, Dennis Carroll, William B Karesh, Carlos Zambrana-Torrelio, W Ian Lipkin, Peter Daszak Lancet 2012; 380: 1956–65 Most pandemics—eg, HIV/AIDS, severe acute respiratory syndrome, pandemic infl uenza—originate in animals, See Comment pages 1883 are caused by viruses, and are driven to emerge by ecological, behavioural, or socioeconomic changes. Despite their and 1884 substantial eff ects on global public health and growing understanding of the process by which they emerge, no This is the third in a Series of pandemic has been predicted before infecting human beings. We review what is known about the pathogens that three papers about zoonoses emerge, the hosts that they originate in, and the factors that drive their emergence. We discuss challenges to their Mailman School of Public control and new eff orts to predict pandemics, target surveillance to the most crucial interfaces, and identify Health (Prof S S Morse PhD), and Center for Infection and prevention strategies. New mathematical modelling, diagnostic, communications, and informatics technologies can Immunity (Prof W I Lipkin MD); identify and report hitherto unknown microbes in other species, and thus new risk assessment approaches are Columbia University, needed to identify microbes most likely to cause human disease. We lay out a series of research and surveillance New York, NY, USA; One Health opportunities and goals that could help to overcome these challenges and move the global pandemic strategy from Institute, School of Veterinary Medicine, University of response to pre-emption.
    [Show full text]
  • How Oli's Actions Put Heads of Two Houses at Odds
    WITHOUT F EAR OR FAVOUR Nepal’s largest selling English daily Vol XXVIII No. 336 | 8 pages | Rs.5 O O Printed simultaneously in Kathmandu, Biratnagar, Bharatpur and Nepalgunj 21.8 C -5.5 C Tuesday, February 02, 2021 | 20-10-2077 Dipayal Jumla How Oli’s actions put heads of two houses at odds Speaker and National Assembly chairman spar over Constitutional Council’s December 15 recommendations, in a brazen display of their partisan allegiance. TIKA R PRADHAN Partisan politics has reached the KATHMANDU, FEB 1 legislature now, which is not a good sign for parliamentary democracy, A day after Speaker Agni Sapkota sent which is already under attack from back recommendations made by the Oli, they say. Constitutional Council, National “Both the factions of Nepal Assembly chair Ganesh Timilsina on Communist Party are constantly Monday reacted to the move, saying attacking the constitution,” said that the Speaker had no authority to Daman Nath Dhungana, a former do so without consulting him. Speaker. The chiefs of Nepal’s bicameral leg- “This is just part of a series of con- islature are clearly at odds. stitutional violations the Nepal Observers say Prime Minister KP Communist Party has been involved Sharma Oli, by dissolving the House in. Now the two factions are in a bid to of Representatives, has by now destroy the constitution both ways— dragged all key institutions of the in conduct and compliance.” country into controversy—the execu- The Constitutional Council led by tive which he heads, the legislature Oli had made recommendations to that elected him to the post and the appoint office bearers at 11 constitu- judiciary, which is considered an inde- tional bodies on December 15, the day pendent institution.
    [Show full text]